Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Node; Prostate × durvalumab × Genitourinary × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 30 Carcinoma, Renal Cell 17 Prostatic Neoplasms 13 Carcinoma, Transitional Cell 11 Melanoma 8 Carcinoma, Non-Small-Cell Lung 7 Breast Neoplasms 7 Uterine Cervical Neoplasms 6 Kidney Neoplasms 6 Non-Muscle Invasive Bladder Neoplasms 5 Triple Negative Breast Neoplasms 4 Small Cell Lung Carcinoma 4 Pancreatic Neoplasms 4 Ovarian Neoplasms 4 Neoplasm Metastasis 4 Colorectal Neoplasms 4 Carcinoma, Merkel Cell 4 Squamous Cell Carcinoma of Head and Neck 3 Head and Neck Neoplasms 3 Carcinoma, Hepatocellular 3 Urothelial Cancer 2 Testicular Neoplasms 2 Stomach Neoplasms 2 Neoplasms 2 Lung Neoplasms 2 Hodgkin Disease 2 Esophageal Neoplasms 2 Endometrial Neoplasms 2 Carcinoma in Situ 2 Carcinoma 2

Interventions

durvalumab 1 Radiosurgery 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03795207 2026-03-31

POSTCARD

Institut Cancerologie de l'Ouest

Phase 2 Active not recruiting

Node; Prostate

Data powered by HemOnc (CC BY 4.0) Colophon ⚡